Cloverfields Capital Group’s Thermo Fisher Scientific TMO Stock Holding History

Cloverfields Capital Group’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-8,765	Closed	-$5.08M	–	99
2025 Q4	$5.08M	Sell	8,765 -411	-4%	-$232K	1.57%	25
2025 Q3	$4.45M	Sell	9,176 -117	-1%	-$54.5K	1.39%	29
2025 Q2	$3.77M	Sell	9,293 -180	-2%	-$75.3K	1.12%	39
2025 Q1	$4.71M	Sell	9,473 -383	-4%	-$207K	1.56%	24
2024 Q4	$5.13M	Buy	9,856 +2	+0%	+$1.1K	1.65%	25
2024 Q3	$6.1M	Sell	9,854 -822	-8%	-$487K	1.97%	15
2024 Q2	$5.9M	Sell	10,676 -96	-0.9%	-$55K	1.99%	17
2024 Q1	$6.26M	Buy	10,772 +581	+6%	+$326K	2.11%	12
2023 Q4	$5.41M	Buy	+10,191	New	+$4.93M	2.12%	9

Other funds holding TMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Cloverfields Capital Group's TMO Position: Q1 2026 in Review

Cloverfields Capital Group sold out of Thermo Fisher Scientific (TMO) in Q1 2026, closing a stake of 8,765 shares — an estimated $5.08M sold.

Cloverfields Capital Group first reported a position in TMO in Q4 2023 and held it in 9 quarters. The position peaked at $6.26M in Q1 2024. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

Cloverfields Capital Group reported no remaining Thermo Fisher Scientific position as of Q1 2026 after selling out during the quarter.
Cloverfields Capital Group sold 8,765 Thermo Fisher Scientific shares in Q1 2026, an estimated $5.08M.
Cloverfields Capital Group first reported a position in Thermo Fisher Scientific in Q4 2023 and held it in 9 quarters.
Cloverfields Capital Group's Thermo Fisher Scientific position peaked at $6.26M in Q1 2024.
2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Cloverfields Capital Group's 13F filing for Q1 2026, filed 14 May 2026.